Прати
Shun Kishimoto
Shun Kishimoto
Urologic Oncology Branch, National Cancer Institute
Верификована је имејл адреса на nih.gov
Наслов
Навело
Навело
Година
Dynamic imaging of LDH inhibition in tumors reveals rapid in vivo metabolic rewiring and vulnerability to combination therapy
N Oshima, R Ishida, S Kishimoto, K Beebe, JR Brender, K Yamamoto, ...
Cell reports 30 (6), 1798-1810. e4, 2020
1112020
Hydrogen sulfide inhibits hypoxia-but not anoxia-induced hypoxia-inducible factor 1 activation in a von hippel-lindau-and mitochondria-dependent manner
S Kai, T Tanaka, H Daijo, H Harada, S Kishimoto, K Suzuki, S Takabuchi, ...
Antioxidants & redox signaling 16 (3), 203-216, 2012
942012
Dynamic Imaging of Glucose and Lactate Metabolism by 13C-MRS without Hyperpolarization
JR Brender, S Kishimoto, H Merkle, G Reed, RE Hurd, AP Chen, ...
Scientific reports 9 (1), 3410, 2019
892019
Evaluation of oxygen dependence on in vitro and in vivo cytotoxicity of photoimmunotherapy using IR-700–antibody conjugates
S Kishimoto, M Bernardo, K Saito, S Koyasu, JB Mitchell, PL Choyke, ...
Free Radical Biology and Medicine 85, 24-32, 2015
572015
Metabolic and physiologic imaging biomarkers of the tumor microenvironment predict treatment outcome with radiation or a hypoxia-activated prodrug in mice
S Matsumoto, S Kishimoto, K Saito, Y Takakusagi, JP Munasinghe, ...
Cancer research 78 (14), 3783-3792, 2018
492018
Pulsed electron paramagnetic resonance imaging: applications in the studies of tumor physiology
S Kishimoto, KI Matsumoto, K Saito, A Enomoto, S Matsumoto, JB Mitchell, ...
Antioxidants & redox signaling 28 (15), 1378-1393, 2018
412018
Pyruvate induces transient tumor hypoxia by enhancing mitochondrial oxygen consumption and potentiates the anti-tumor effect of a hypoxia-activated prodrug TH-302
Y Takakusagi, S Matsumoto, K Saito, M Matsuo, S Kishimoto, ...
PloS one 9 (9), e107995, 2014
412014
Tensor image enhancement and optimal multichannel receiver combination analyses for human hyperpolarized 13C MRSI
HY Chen, AW Autry, JR Brender, S Kishimoto, MC Krishna, M Vareth, ...
Magnetic resonance in medicine 84 (6), 3351-3365, 2020
382020
In Vivo Application of Proton-Electron Double-Resonance Imaging
S Kishimoto, MC Krishna, VV Khramtsov, H Utsumi, DJ Lurie
Antioxidants & redox signaling 28 (15), 1345-1364, 2018
352018
Hypoxia-activated prodrug evofosfamide treatment in pancreatic ductal adenocarcinoma xenografts alters the tumor redox status to potentiate radiotherapy
S Kishimoto, JR Brender, GVR Chandramouli, Y Saida, K Yamamoto, ...
Antioxidants & Redox Signaling 35 (11), 904-915, 2021
342021
Molecular imaging of the tumor microenvironment reveals the relationship between tumor oxygenation, glucose uptake, and glycolysis in pancreatic ductal adenocarcinoma
K Yamamoto, JR Brender, T Seki, S Kishimoto, N Oshima, R Choudhuri, ...
Cancer research 80 (11), 2087-2093, 2020
292020
Radiotherapy Synergizes with the Hypoxia-Activated Prodrug Evofosfamide: In Vitro and In Vivo Studies
Y Takakusagi, S Kishimoto, S Naz, S Matsumoto, K Saito, CP Hart, ...
Antioxidants & Redox Signaling 28 (2), 131-140, 2018
292018
Imaging of glucose metabolism by 13C-MRI distinguishes pancreatic cancer subtypes in mice
S Kishimoto, JR Brender, DR Crooks, S Matsumoto, T Seki, N Oshima, ...
Elife 8, e46312, 2019
282019
Fentanyl activates hypoxia-inducible factor 1 in neuronal SH-SY5Y cells and mice under non-hypoxic conditions in a μ-opioid receptor-dependent manner
H Daijo, S Kai, T Tanaka, T Wakamatsu, S Kishimoto, K Suzuki, H Harada, ...
European journal of pharmacology 667 (1-3), 144-152, 2011
252011
Hypoxia imaging as a guide for hypoxia-modulated and hypoxia-activated therapy
JR Brender, Y Saida, N Devasahayam, MC Krishna, S Kishimoto
Antioxidants & Redox Signaling 36 (1-3), 144-159, 2022
232022
Molecular imaging of tumor photoimmunotherapy: Evidence of photosensitized tumor necrosis and hemodynamic changes
S Kishimoto, N Oshima, K Yamamoto, J Munasinghe, ...
Free Radical Biology and Medicine 116, 1-10, 2018
232018
A multimodal molecular imaging study evaluates pharmacological alteration of the tumor microenvironment to improve radiation response
Y Takakusagi, S Naz, K Takakusagi, M Ishima, H Murata, K Ohta, M Miura, ...
Cancer research 78 (24), 6828-6837, 2018
222018
Multimodal molecular imaging detects early responses to immune checkpoint blockade
Y Saida, JR Brender, K Yamamoto, JB Mitchell, MC Krishna, S Kishimoto
Cancer research 81 (13), 3693-3705, 2021
212021
Trehalose as an alternative to glycerol as a glassing agent for in vivo DNP MRI
JR Brender, S Kishimoto, GR Eaton, SS Eaton, Y Saida, J Mitchell, ...
Magnetic resonance in medicine 85 (1), 42-48, 2021
182021
Multimodality imaging identifies distinct metabolic profiles in vitro and in vivo
MA Neveu, G De Preter, V Marchand, A Bol, JR Brender, K Saito, ...
Neoplasia 18 (12), 742-752, 2016
172016
Систем тренутно не може да изврши ову радњу. Пробајте поново касније.
Чланци 1–20